z-logo
open-access-imgOpen Access
COVID-19 Outcomes in Patients Undergoing B Cell Depletion Therapy and Those with Humoral Immunodeficiency States: A Scoping Review
Author(s) -
Jessica M Jones,
Aiman Faruqi,
James K. Sullivan,
Cassandra Calabrese,
Leonard H. Calabrese
Publication year - 2021
Publication title -
pathogens and immunity
Language(s) - English
Resource type - Journals
ISSN - 2469-2964
DOI - 10.20411/pai.v6i1.435
Subject(s) - humoral immunity , immunology , immunodeficiency , common variable immunodeficiency , medicine , disease , immunity , confounding , immune system , covid-19 , antibody , infectious disease (medical specialty)
The role of humoral immunity has been well established in reducing infection risk and facilitating viral clearance in patients with COVID-19. However, the relationship between specific antibody responses and severity of COVID-19 is less well understood.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here